Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · derivative · entry 11 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F6 · derivative.exercise_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 50% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F6 · derivative.expiration_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 50% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 13,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · derivative · entry 10 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,104 Underlying: Ordinary Shares · 13,104 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F5 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 50% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F5 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 50% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 20,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · derivative · entry 9 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,442 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F4 · derivative.exercise_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 117% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025 F4 · derivative.expiration_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 117% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025 Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 20,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · derivative · entry 8 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,442 Underlying: Ordinary Shares · 20,442 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 117% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F3 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 117% target) awarded on March 20, 2023. 100% of the performance-based Restricted Stock Units were granted and vested on March 20, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · derivative · entry 7 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,297 Underlying: Ordinary Shares · 8,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F2 · derivative.exercise_date: Relates to 25% vesting of the Restricted Stock Units granted on Mach 20, 2023, the final 25% will vest March 20, 2027. F2 · derivative.expiration_date: Relates to 25% vesting of the Restricted Stock Units granted on Mach 20, 2023, the final 25% will vest March 20, 2027. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 7,347 | $11.82 | $86,841.54 |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 6 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,590 Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 13,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 5 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 11,460 | $11.82 | $135,457.20 |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 4 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 258,833 Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 20,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 3 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 4,648 | $11.82 | $54,939.36 |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 2 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,851 Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 15:53 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000048 · wk-form4_1774281215.xml · nonDerivative · entry 1 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 254,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · derivative · entry 14 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F7 · derivative.exercise_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F7 · derivative.expiration_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
GrantRestricted Stock Units · Derivative | 5,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · derivative · entry 13 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,738 Underlying: Ordinary Shares · 5,738 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F6 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F6 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 6,763 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · derivative · entry 12 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F5 · derivative.exercise_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F5 · derivative.expiration_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
GrantRestricted Stock Units · Derivative | 6,763 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · derivative · entry 11 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,763 Underlying: Ordinary Shares · 6,763 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F4 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F4 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 921 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · derivative · entry 10 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,848 Underlying: Ordinary Shares · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. F3 · derivative.expiration_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Tax withholdingOrdinary Shares | 2,324 | $11.82 | $27,469.68 |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 8 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,882 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionOrdinary Shares | 5,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 7 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Tax withholdingOrdinary Shares | 2,739 | $11.82 | $32,374.98 |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 6 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,468 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionOrdinary Shares | 6,763 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 5 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Tax withholdingOrdinary Shares | 373 | $11.82 | $4,408.86 |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 4 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,444 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:43 UTC |
Moorefield Jeffrey C.See Remarks
|
Exercise / conversionOrdinary Shares | 921 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000044 · wk-form4_1773927809.xml · nonDerivative · entry 3 Moorefield Jeffrey C. · CIK 0001640363 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · derivative · entry 14 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F7 · derivative.exercise_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F7 · derivative.expiration_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
GrantRestricted Stock Units · Derivative | 5,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · derivative · entry 13 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,940 Underlying: Ordinary Shares · 5,940 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F6 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F6 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 7,001 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · derivative · entry 12 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F5 · derivative.exercise_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F5 · derivative.expiration_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
GrantRestricted Stock Units · Derivative | 7,001 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · derivative · entry 11 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,001 Underlying: Ordinary Shares · 7,001 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F4 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F4 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · derivative · entry 10 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,912 Underlying: Ordinary Shares · 954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. F3 · derivative.expiration_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Tax withholdingOrdinary Shares | 2,569 | $11.82 | $30,365.58 |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 8 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,310 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionOrdinary Shares | 5,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 7 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Tax withholdingOrdinary Shares | 3,028 | $11.82 | $35,790.96 |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 6 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,939 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionOrdinary Shares | 7,001 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 5 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Tax withholdingOrdinary Shares | 413 | $11.82 | $4,881.66 |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 4 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,966 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:42 UTC |
MEAD HOWARD IOANSee Remarks
|
Exercise / conversionOrdinary Shares | 954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000042 · wk-form4_1773927763.xml · nonDerivative · entry 3 MEAD HOWARD IOAN · CIK 0001964326 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:41 UTC |
LAWDAY MARK JAMESSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 5,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000040 · wk-form4_1773927705.xml · derivative · entry 2 LAWDAY MARK JAMES · CIK 0001964245 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,265 Underlying: Ordinary Shares · 5,265 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F3 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:41 UTC |
LAWDAY MARK JAMESSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 6,206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000040 · wk-form4_1773927705.xml · derivative · entry 1 LAWDAY MARK JAMES · CIK 0001964245 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,206 Underlying: Ordinary Shares · 6,206 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F2 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F2 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:41 UTC |
Wardlow GrahamSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 12,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000038 · wk-form4_1773927665.xml · derivative · entry 2 Wardlow Graham · CIK 0001761477 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,218 Underlying: Ordinary Shares · 12,218 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F3 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:41 UTC |
Wardlow GrahamSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 14,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000038 · wk-form4_1773927665.xml · derivative · entry 1 Wardlow Graham · CIK 0001761477 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,400 Underlying: Ordinary Shares · 14,400 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F2 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F2 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:40 UTC |
Webster StephenChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000036 · wk-form4_1773927622.xml · derivative · entry 2 Webster Stephen · CIK 0001760464 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,083 Underlying: Ordinary Shares · 12,083 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F3 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:40 UTC |
Webster StephenChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 14,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000036 · wk-form4_1773927622.xml · derivative · entry 1 Webster Stephen · CIK 0001760464 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,241 Underlying: Ordinary Shares · 14,241 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F2 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F2 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 12,268 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · derivative · entry 14 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,540 Underlying: Ordinary Shares · 12,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F7 · derivative.exercise_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. F7 · derivative.expiration_date: Represents 25% of the Restricted Stock Units granted on March 18, 2024. The remaining Restricted Stock Units will vest in two equal tranches on March 18, 2027 and 2028. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 76,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · derivative · entry 13 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 76,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F6 · derivative.exercise_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F6 · derivative.expiration_date: Represents the 100% exercise of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 76,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · derivative · entry 12 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,208 Underlying: Ordinary Shares · 76,208 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F5 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. F5 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 125% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of relative total shareholder return (TSR) goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 89,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · derivative · entry 11 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 89,823 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F4 · derivative.exercise_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F4 · derivative.expiration_date: Represents the 100% vesting of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 89,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · derivative · entry 10 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,823 Underlying: Ordinary Shares · 89,823 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. F3 · derivative.exercise_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. F3 · derivative.expiration_date: Represents the grant of performance-based Restricted Stock Units (at 221% target) awarded on March 18, 2024. 100% of the performance-based Restricted Stock Units were granted and vested on March 18, 2026 upon the achievement of EPS growth goals for the performance period ended December 31, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 6,878 | $11.82 | $81,297.96 |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 8 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,209 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 12,268 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 7 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 42,723 | $11.82 | $504,985.86 |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 6 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,819 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 76,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 5 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 50,356 | $11.82 | $595,207.92 |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 4 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,334 Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 13:39 UTC |
Butcher AndrewDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 89,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001096056-26-000034 · wk-form4_1773927560.xml · nonDerivative · entry 3 Butcher Andrew · CIK 0001761420 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 257,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.